Ledger.Open graph →
SEC Form D · Amendment · filed August 7, 2018

Outlier BioPharma Inc

Offering
$5.0M
Sold
$50K
Exemption
Rule 506(b)
Industry
Other
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Peter K. Rogal · West Bridgewater, MAExec · DirectorSteven Ross · Wellesley Hills, MADirectorErin Rosenthal · Salt Lake City, UTExec · DirectorAdam Koppel · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗